A potent D3 receptor agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(+)-PD 128907 (hydrochloride)

Item No. 21235

Technical Information
Formal Name
3,4,4aR,10bR-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol, monohydrochloride
CAS Number
300576-59-4
Molecular Formula
C14H19NO3 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 10 mg/mlDMSO: 15 mg/mlEthanol: slightlyPBS (pH 7.2): 0.5 mg/ml
λmax
228, 297 nm
SMILES
OC1=CC=C(OC[C@]2([H])[C@]3([H])OCCN2CCC)C3=C1.Cl
InChi Code
InChI=1S/C14H19NO3.ClH/c1-2-5-15-6-7-17-14-11-8-10(16)3-4-13(11)18-9-12(14)15;/h3-4,8,12,14,16H,2,5-7,9H2,1H3;1H/t12-,14-;/m1./s1
InChi Key
DCFXOTRONMKUJB-QMDUSEKHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    (+)-PD 128907 is a potent agonist of the dopamine 3 (D3) receptor (Ki = 1 nM).1,2 It shows selectivity for D3 over D2 and D4 receptors (Kis = 1.2 and 7 µM, respectively).1 Low doses of (+)-PD 128907 (13 µg/kg, s.c.) reduce spontaneous locomotor activity in rats.3 It blocks stereotypy induced by the NMDA receptor antagonist (+)-MK-801 (Item No. 10009019) in mice.4 (+)-PD 128907 is used in animal models to study the role of the D3 receptor in nervous system disorders, such as schizophrenia, Parkinson’s disease, and depression.5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Akunne, H.C., Towers, P., Ellis, G.J., et alCharacterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells. Life Sci. 57(15), 1401-1410 (1995).

    2. Pugsley, T.A., Davis, M.D., Akunne, H.C., et alNeurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275(3), 1355-1366 (1995).

    3. Bristow, L.J., Cook, G.P., Gay, J.C., et alThe behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat. Neuropharmacology 35(3), 285-294 (1996).

    4. Witkin, J., Gasior, M., Acri, J., et alAtypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907. Eur. J. Pharmacol. 347(2-3), R1-R3 (1998).

    5. Carcinella, S., Drui, G., Boulet, S., et alImplication of dopamine D3 receptor activation in the reversion of Parkinson’s disease-related motivational deficits. Transl. Psychiatry 4(6), e401 (2014).

    6. Gil-Mast, S., Kortagere, S., Kota, K., et alAn amino acid residue in the second extracellular loop determines the agonist-dependent tolerance property of the human D3 dopamine receptor. ACS Chem Neurosci. 4(6), 940-951 (2013).